Many of the most devastating infectious diseases are caused by RNA viruses, and Model Medicines is working on one compound to ...

The article " After a Reset Year, Is Moderna Stock Poised for a Comeback? " first appeared on MarketBeat.

In this review of RNA therapies, we paint an overview of what’s going on in a field that is addressing a number of diseases.

"We remain focused on our three strategic priorities: driving sales growth, delivering up to 10 product approvals over the ...

Share prices of Moderna (NASDAQ: MRNA) plummeted 58% in 2024, ranking among the worst performers in the S&P 500 index. The ...

Queen’s University Belfast virologist Dr Connor Bamford discusses his research on the Covid-19 vaccine and the challenges of his work.

HMPV mainly affects the respiratory system and can cause a wide range of illnesses, from mild cold-like symptoms to severe ...

Quotient Therapeutics, a biotech company founded in 2022, hopes to take this transatlantic model and commercialise it. Its main research lab is in Great Chesterford, a village just outside Cambridge, ...

Consumers are clear in this new survey that they do not want to consume cow’s milk affected by bird flu virus, even if the ...

Moderna has been testing an mRNA candidate for influenza viruses like the H5 and H7 strains that are seen as pandemic threats ...

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it will host a webcast and conference call on February 10, 2025, at 4:30 p.m. ET to discuss its financial results for the fiscal ...

Pulmonary fibrosis is a rare, chronic disease that causes scarring in the lungs, making breathing difficult for people who suffer with it. And, as University of South Florida pulmonologist Dr. Jose ...